Flarex: payments to doctors
Payments that named Flarex as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $923K
- Providers
- 4,831
- Transactions
- 11,572
- Average per transaction
- $80
The per-transaction average — $80 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,831 providers the average total is $191, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Eyevance Pharmaceuticals LLC | $907,220 | 98.3% |
| Harrow Eye, LLC | $15,931 | 1.7% |